These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 18520050)

  • 21. Berberine-improved visceral white adipose tissue insulin resistance associated with altered sterol regulatory element-binding proteins, liver x receptors, and peroxisome proliferator-activated receptors transcriptional programs in diabetic hamsters.
    Li GS; Liu XH; Zhu H; Huang L; Liu YL; Ma CM; Qin C
    Biol Pharm Bull; 2011; 34(5):644-54. PubMed ID: 21532151
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Possible therapeutic potential of berberine in the treatment of STZ plus HFD-induced diabetic osteoporosis.
    Xie H; Wang Q; Zhang X; Wang T; Hu W; Manicum T; Chen H; Sun L
    Biomed Pharmacother; 2018 Dec; 108():280-287. PubMed ID: 30223099
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The effects of berberine on hyperhomocysteinemia and hyperlipidemia in rats fed with a long-term high-fat diet.
    Chang XX; Yan HM; Xu Q; Xia MF; Bian H; Zhu TF; Gao X
    Lipids Health Dis; 2012 Jul; 11():86. PubMed ID: 22762542
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin.
    Wang C; Li J; Lv X; Zhang M; Song Y; Chen L; Liu Y
    Eur J Pharmacol; 2009 Oct; 620(1-3):131-7. PubMed ID: 19686728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Daming capsule, a hypolipidaemic drug, lowers blood lipids by activating the AMPK signalling pathway.
    Bian Y; Li X; Li X; Ju J; Liang H; Hu X; Dong L; Wang N; Li J; Zhang Y; Yang B
    Biomed Pharmacother; 2019 Sep; 117():109176. PubMed ID: 31387185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. "2-(4-Fluorobenzamido)-4-methylthiazole-5-carboxylic acid" a novel thiazole compound, ameliorates insulin sensitivity and hyperlipidaemia in streptozotocin-induced diabetic rats: Plausible role of inflammatory and oxidative stress markers.
    Paudel YN; Ali MR; Adil M; Bawa S; Sharma M
    Biomed Pharmacother; 2017 Nov; 95():1232-1241. PubMed ID: 28938514
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sodium caprate augments the hypoglycemic effect of berberine via AMPK in inhibiting hepatic gluconeogenesis.
    Zhang M; Lv X; Li J; Meng Z; Wang Q; Chang W; Li W; Chen L; Liu Y
    Mol Cell Endocrinol; 2012 Nov; 363(1-2):122-30. PubMed ID: 22922125
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Carnosine decreased oxidation and glycation products in serum and liver of high-fat diet and low-dose streptozotocin-induced diabetic rats.
    Aydın AF; Bingül İ; Küçükgergin C; Doğan-Ekici I; Doğru Abbasoğlu S; Uysal M
    Int J Exp Pathol; 2017 Oct; 98(5):278-288. PubMed ID: 29205589
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Modulatory effect of green tea extract on hepatic key enzymes of glucose metabolism in streptozotocin and high fat diet induced diabetic rats.
    Sundaram R; Naresh R; Shanthi P; Sachdanandam P
    Phytomedicine; 2013 May; 20(7):577-84. PubMed ID: 23453307
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Beneficial effect of carvone, a dietary monoterpene ameliorates hyperglycemia by regulating the key enzymes activities of carbohydrate metabolism in streptozotocin-induced diabetic rats.
    Muruganathan U; Srinivasan S
    Biomed Pharmacother; 2016 Dec; 84():1558-1567. PubMed ID: 27876337
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ergostatrien-3β-ol from Antrodia camphorata inhibits diabetes and hyperlipidemia in high-fat-diet treated mice via regulation of hepatic related genes, glucose transporter 4, and AMP-activated protein kinase phosphorylation.
    Kuo YH; Lin CH; Shih CC
    J Agric Food Chem; 2015 Mar; 63(9):2479-89. PubMed ID: 25693659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pioglitazone-induced bone loss in diabetic rats and its amelioration by berberine: A portrait of molecular crosstalk.
    Adil M; Mansoori MN; Singh D; Kandhare AD; Sharma M
    Biomed Pharmacother; 2017 Oct; 94():1010-1019. PubMed ID: 28810524
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Anti-diabetic activity and potential mechanism of total flavonoids of Selaginella tamariscina (Beauv.) Spring in rats induced by high fat diet and low dose STZ.
    Zheng XK; Zhang L; Wang WW; Wu YY; Zhang QB; Feng WS
    J Ethnopharmacol; 2011 Sep; 137(1):662-8. PubMed ID: 21718776
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of iridoid glucoside on streptozotocin induced diabetic rats and its role in regulating carbohydrate metabolic enzymes.
    Sundaram R; Naresh R; Ranadevan R; Shanthi P; Sachdanandam P
    Eur J Pharmacol; 2012 Jan; 674(2-3):460-7. PubMed ID: 22094064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Berberine is a potent agonist of peroxisome proliferator activated receptor alpha.
    Yu H; Li C; Yang J; Zhang T; Zhou Q
    Front Biosci (Landmark Ed); 2016 Jun; 21(5):1052-60. PubMed ID: 27100490
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Regulation of hepatic carbohydrate metabolism by Selenium during diabetes.
    Chen H; Qiu Q; Zou C; Dou L; Liang J
    Chem Biol Interact; 2015 May; 232():1-6. PubMed ID: 25779343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Canagliflozin protects against non-alcoholic steatohepatitis in type-2 diabetic rats through zinc alpha-2 glycoprotein up-regulation.
    Kabil SL; Mahmoud NM
    Eur J Pharmacol; 2018 Jun; 828():135-145. PubMed ID: 29608898
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypolipidemic activity of 18beta-glycyrrhetinic acid on streptozotocin-induced diabetic rats.
    Kalaiarasi P; Kaviarasan K; Pugalendi KV
    Eur J Pharmacol; 2009 Jun; 612(1-3):93-7. PubMed ID: 19361497
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bezafibrate ameliorates diabetes via reduced steatosis and improved hepatic insulin sensitivity in diabetic TallyHo mice.
    Franko A; Neschen S; Rozman J; Rathkolb B; Aichler M; Feuchtinger A; Brachthäuser L; Neff F; Kovarova M; Wolf E; Fuchs H; Häring HU; Peter A; Hrabě de Angelis M
    Mol Metab; 2017 Mar; 6(3):256-266. PubMed ID: 28271032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acceleration of development of diabetic cataract by hyperlipidemia and low high-density lipoprotein in rats.
    Tsutsumi K; Inoue Y; Yoshida C
    Biol Pharm Bull; 1999 Jan; 22(1):37-41. PubMed ID: 9989659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.